Literature DB >> 22142361

Processes underlying treatment success and failure in assertive community treatment.

Laura G Stull1, John H McGrew, Michelle P Salyers.   

Abstract

BACKGROUND: Processes underlying success and failure in assertive community treatment (ACT), a widely investigated treatment model for persons with severe mental illness, are poorly understood. AIMS: The purpose of the current study was to examine processes in ACT by (1) understanding how consumers and staff describe the processes underlying treatment success and failure and (2) comparing processes identified by staff and consumers.
METHOD: Investigators conducted semi-structured interviews with 25 staff and 23 consumers from four ACT teams.
RESULTS: Both staff and consumers identified aspects of the ACT team itself as the most critical in the process of consumer success. For failure, consumers identified consumer characteristics as most critical and staff identified lack of social relationships. Processes underlying failure were not viewed as merely the opposite of processes underlying success. In addition, there was notable disagreement between staff and consumers on important processes.
CONCLUSIONS: Findings overlap with critical ingredients identified in previous studies, including aspects of the ACT team, social involvement and employment. In contrast to prior studies, there was little emphasis on hospitalizations and greater emphasis on not abusing substances, obtaining wants and desires, and consumer characteristics.

Entities:  

Mesh:

Year:  2011        PMID: 22142361      PMCID: PMC4023683          DOI: 10.3109/09638237.2011.629239

Source DB:  PubMed          Journal:  J Ment Health        ISSN: 0963-8237


  18 in total

1.  Therapeutic agents of assertive community treatment.

Authors:  M Chinman; M Allende; P Bailey; J Maust; L Davidson
Journal:  Psychiatr Q       Date:  1999

2.  A meta-analysis of the effectiveness of mental health case management over 20 years.

Authors:  S J Ziguras; G W Stuart
Journal:  Psychiatr Serv       Date:  2000-11       Impact factor: 3.084

Review 3.  Real qualitative researchers do not count: the use of numbers in qualitative research.

Authors:  M Sandelowski
Journal:  Res Nurs Health       Date:  2001-06       Impact factor: 2.228

4.  An exploratory study of what clients like least about assertive community treatment.

Authors:  John H McGrew; Robert G Wilson; Gary R Bond
Journal:  Psychiatr Serv       Date:  2002-06       Impact factor: 3.084

5.  Case managers' perspectives on critical ingredients of assertive community treatment and on its implementation.

Authors:  John H McGrew; Bernice Pescosolido; Eric Wright
Journal:  Psychiatr Serv       Date:  2003-03       Impact factor: 3.084

6.  A phenomenological account of users' experiences of assertive community treatment.

Authors:  Jay Watts; Stefan Priebe
Journal:  Bioethics       Date:  2002-09       Impact factor: 1.898

7.  Critical ingredients of assertive community treatment: judgments of the experts.

Authors:  J H McGrew; G R Bond
Journal:  J Ment Health Adm       Date:  1995

8.  The client experience of assertive community treatment: a qualitative study.

Authors:  Linda R Leiphart; Madaline G Barnes
Journal:  Psychiatr Rehabil J       Date:  2005

9.  How do people who receive assertive community treatment experience this service?

Authors:  Terry Krupa; Shirley Eastabrook; Louise Hern; Diane Lee; Robert North; Karen Percy; Barbie Von Briesen; Geoff Wing
Journal:  Psychiatr Rehabil J       Date:  2005

10.  Participant perspectives on satisfaction with assertive community treatment.

Authors:  Cristina Redko; Janet Durbin; Donald Wasylenki; Terry Krupa
Journal:  Psychiatr Rehabil J       Date:  2004
View more
  1 in total

1.  Evaluation of new flexible and integrative psychiatric treatment models in Germany- assessment and preliminary validation of specific program components.

Authors:  Jakob Johne; Sebastian von Peter; Julian Schwarz; Jürgen Timm; Martin Heinze; Yuriy Ignatyev
Journal:  BMC Psychiatry       Date:  2018-09-03       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.